focus -WSS

focus

author：explore 2025-09-06 03:54:25 - browse：3316

Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the fallout over the FTC’s move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves an unanswered question. We also discuss the latest news in the life sciences, including Pfizer’s downbeat future, Vertex Pharmaceuticals’ next big thing, and a newly minted biotech VC with a very famous name.

For more on what we cover, here’s the FTC news; here’s more from Maze Therapeutics; here’s the Pfizer news; here’s the latest on Vertex; here’s the story behind its pain drug; here’s the Reed Jobs profile; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Humans aren't the only ones with an imagination. Rats have it too

knowledge

WSS

Medicare proceeds with plan to claw back hospital funds

Infant mortality in U.S. rose last year for first time in decades: CDC

Drug repurposing or repositioning? The language matters

Drug repurposing or repositioning? The language matters

Sports medicine is finally prioritizing gender equality

Affirmative action in medical school literally saved lives

leisure time

focus

entertainment

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Guidelines to prevent youth baseball injuries need more muscle

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Peter Hotez and the public health issue of online harassment

Explaining an after

Malaria cases in Florida and Texas: Here’s what you need to know

After Sarepta trial failure, Duchenne families brace for more debate

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Wikipedia

Coloradans with cystic fibrosis could lose access to Trikafta

Hollywood unions extend contract negotiations for actors

Key Senate panel to consider PBM, drug pricing reform package

Gene therapy’s promise and the high cost of hope

Affirmative action in medical school literally saved lives

What is microchimerism and how does it affect maternal health?

knowledge

hotspot

entertainment

knowledge